# A Study of AK112 for Advanced Solid Tumors

> **NCT04597541** · PHASE1,PHASE2 · COMPLETED · sponsor: **Akeso** · enrollment: 59 (actual)

## Conditions studied

- Solid Tumor, Adult

## Interventions

- **DRUG:** AK112

## Key facts

- **NCT ID:** NCT04597541
- **Lead sponsor:** Akeso
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-21
- **Primary completion:** 2022-03-31
- **Final completion:** 2024-07-15
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2025-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04597541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04597541, "A Study of AK112 for Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04597541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*